Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

32.44
-0.9800-2.93%
Post-market: 32.440.00000.00%16:34 EDT
Volume:659.32K
Turnover:21.50M
Market Cap:1.03B
PE:18.75
High:33.61
Open:33.56
Low:32.37
Close:33.42
52wk High:50.79
52wk Low:23.23
Shares:31.61M
Float Shares:28.09M
Volume Ratio:0.86
T/O Rate:2.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.73
EPS(LYR):1.73
ROE:23.70%
ROA:7.27%
PB:3.40
PE(LYR):18.75

Loading ...

Collegium Pharmaceutical Is Maintained at Buy by Needham

Dow Jones
·
Feb 27

Stock Track | Collegium Pharmaceutical Plummets 8.74% Intraday on Q4 Earnings and Revenue Misses

Stock Track
·
Feb 26

Collegium Pharmaceutical Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

Collegium Pharma Q4 Jornay PM net revenue jumps 57% to USD 45.9 million

Reuters
·
Feb 26

Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

THOMSON REUTERS
·
Feb 26

Collegium Pharmaceutical Inc - Qtrly Earnings per Share $0.46

THOMSON REUTERS
·
Feb 26

Collegium Pharmaceutical Inc - Reaffirms Full-Year 2026 Guidance

THOMSON REUTERS
·
Feb 26

Collegium Pharmaceutical Inc Q4 Shr View $2.33 -- Lseg Ibes Data

THOMSON REUTERS
·
Feb 26

Collegium Pharmaceutical Inc - Qtrly Adjusted Earnings per Share $2.04

THOMSON REUTERS
·
Feb 26

Collegium Pharmaceutical Q4 Adjusted EPS USD 2.04 VS. Ibes Estimate USD 2.33

THOMSON REUTERS
·
Feb 26

Collegium Pharmaceutical Q4 Revenue USD 205.4 Million VS. Ibes Estimate USD 206.4 Million

THOMSON REUTERS
·
Feb 26

Collegium Pharmaceutical - Reaffirmed Full-Year 2026 Guidance

THOMSON REUTERS
·
Feb 26

Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical

GlobeNewswire
·
Feb 23

Earning Preview: Collegium Pharmaceutical this quarter’s revenue is expected to increase by 14.78%, and institutional views are predominantly bullish

Earnings Agent
·
Feb 19

Collegium Pharmaceutical price target raised to $58 from $55 at Truist

TIPRANKS
·
Feb 10

Truist Adjusts Price Target on Collegium Pharmaceutical to $58 From $55, Maintains Buy Rating

MT Newswires Live
·
Feb 10

Collegium Pharmaceutical management to meet with Truist

TIPRANKS
·
Feb 06

What Collegium Pharmaceutical (COLL)'s Revenue Surge and Low Valuation Means For Shareholders

Simply Wall St.
·
Feb 03

Collegium Pharmaceutical Showcases New Real-World Data on Jornay PM at APSARD 2026

Reuters
·
Jan 15

Does Collegium’s 2026 Revenue Guidance After Insider Sales Change The Bull Case For COLL?

Simply Wall St.
·
Jan 15